mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.2 |